Drug Profile
Research programme: cancer therapeutics - Bionovo
Alternative Names: AA102; BN-AM-206; BN-DI-110; BN-EJ-111; BN-GS-107; BN-LJ-114; BN-PC-201; BN-PL-203; BN-RU-119; BN-SA-204; BN-SG-102; BN107; BN108; VS 101Latest Information Update: 20 Jan 2016
Price :
$50
*
At a glance
- Originator Bionovo
- Class
- Mechanism of Action Apoptosis stimulants; MTORC1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer